Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
R1 RCM Reports Second Quarter 2024 Results
-
Microbix Schedules Release of Results for Q3 Fiscal 2024
-
PLBY Group Enters into New Playboy Shop Licensing Agreement
-
Supporting Better Workplace Cultures, Atana’s “Uncomfortable Conversations” Helps Managers Address Touchy Subjects
-
Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
AYR Wellness Reports Second Quarter 2024 Results
-
EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments
-
BioCardia to Host Q2 2024 Corporate Update and Financial Results Conference Call on August 13, 2024
-
Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
-
BioXcel Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
-
Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study in Wet AMD
-
atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Indaptus Therapeutics, Inc. Announces $3.0 Million Registered Direct Offering and Concurrent Private Placement
-
Endexx Corporation Issues Correction and Highlights Revenue Growth
-
Aduro Clean Technologies Announces Grant of Stock Options
-
Advantage Solutions Reports 2024 Second Quarter Results and Reaffirms its Full-Year Outlook
-
Chicago Atlantic Real Estate Finance Announces Second Quarter 2024 Financial Results
-
Stella-Jones Announces Second Quarter Results
-
Osisko Development Provides Exploration Update at Tintic Project
-
Applied Therapeutics Reports Second Quarter 2024 Financial Results
-
Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
-
Editas Medicine Announces Second Quarter 2024 Results and Business Updates
-
Creative Realities, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call Information
-
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
-
Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
-
Regina Graul, Ph.D., Promoted to Chief Executive Officer
-
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
-
Shenandoah Telecommunications Company Reports Second Quarter 2024 Results
-
Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024
-
Sparkle Pioneers Network-as-a-Service (NaaS) with Quantum-Safe Internet Use Case
-
Man Group PLC : Form 8.3 - Keywords Studios plc
-
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
-
Man Group PLC : Form 8.3 - Crest Nicholson Holdings plc
-
Man Group PLC : Form 8.3 - Bellway plc
-
OKX Wallet Now Integrated with Unibase
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
Playtika Holding Corp. Reports Q2 2024 Financial Results
-
OKX Wallet Now Integrated with Chirpley
-
SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Correction: Half-Yearly Results
-
Pharmacosmos Group to Acquire G1 Therapeutics
-
Presence of High Titanium Content in the Northern Sector of the Foothills Property
-
Taboola Reports Strong Q2 2024, Beating Revenues, ex-TAC and Adj. EBITDA; Reiterating ex-TAC, Adj. EBITDA and Free Cash Flow Guidance in 2024
-
Hollywood Star Cuts Expands Through Strategic Agreement With Utah Based Haircare Franchise Group
-
COURTOIS SA : Variation droits de vote 07/2024
-
Netcompany - Transactions in connection with share buyback programme
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
-
Enlight Renewable Energy Reports Second Quarter 2024 Financial Results
